Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for ophthalmic surgery and perfusate, which is applied to surgical drugs, active ingredients of alkaline/alkaline earth metal chlorides, drug combinations, etc., can solve the problem of no perfusate, etc., and achieve the effect of shortening time, reducing surgical damage, and easy operation
Active Publication Date: 2010-09-29
SCHOOL OF OPHTHALMOLOGY & OPTOMETRY WENZHOU MEDICAL COLLEGE
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] In summary, the current literature search shows that in order to achieve the purpose of increasing the visibility of intraocular tissues, the existing domestic and foreign literatures are all about the research on dyes in intraocular surgery, but there is no research on perfusion fluid.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0025]Example 1: The special colored perfusion solution for ophthalmic surgery includes sodium chloride: 6.6mg / ml, which is 1650mg / 250ml, potassium chloride: 0.36mg / ml, which is 90mg / 250ml, calcium chloride: 0.18mg / ml, which is 45mg / 250ml , magnesium sulfate: 0.3mg / ml or 75mg / 250ml, sodium bicarbonate: 2.1mg / ml or 525mg / 250ml, sodium fluorescein: 1mg / 250ml. Specifications: 250ml, 500ml.
Embodiment 2
[0026] Embodiment 2: The special colored perfusion solution for ophthalmic surgery includes sodium chloride: 6.6mg / ml, which is 1650mg / 250ml, potassium chloride: 0.36mg / ml, which is 90mg / 250ml, calcium chloride: 0.18mg / ml, which is 45mg / 250ml , magnesium sulfate: 0.3mg / ml or 75mg / 250ml, sodium bicarbonate: 2.1mg / ml or 525mg / 250ml, sodium fluorescein: 10mg / 250ml. Specifications: 250ml, 500ml
Embodiment 3
[0027] Example 3: The special colored perfusion solution for ophthalmic surgery includes sodium chloride: 6.6mg / ml, which is 1650mg / 250ml, potassium chloride: 0.36mg / ml, which is 90mg / 250ml, calcium chloride: 0.18mg / ml, which is 45mg / 250ml , magnesium sulfate: 0.3mg / ml or 75mg / 250ml, sodium bicarbonate: 2.1mg / ml or 525mg / 250ml, sodium fluorescein: 2.5mg / 250ml. Specifications: 250ml, 500ml.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The present invention relates to a colored perfusion liquid exclusively for ophthalmic surgery. The colored perfusion liquid exclusively for ophthalmic surgery of the present invention includes conventional ophthalmic balanced salt solution and is characterized in that the present invention further contains 0.001 to 0.1mg / ml fluorescein sodium. The present invention firstly proposes the intraocular colored perfusion liquid and a concept of colored surgery, the present invention has the advantages that: the present invention can be filled in the anterior chamber, vitreous body, lens capsular bag and other lacunas, and can form the contrast with the intraocular transparent and semi-permeable membrane tissues, such as, cornea, lens capsule membrane, lens, vitreous body, retina and so on, therefore, the operator can identify such structures easily and the tissues which are difficult to identify become visible, therefore, the surgery becomes easy, the operation is accurate, the time is shorten, the retina, lens capsule membrane and other main structures are protected, the surgical complications are reduced, and better surgical effects are achieved accordingly. In addition, the present invention changes and overcomes the problems that the past localized staining method is time-consuming and needs to rinse, the surgical process is complicated, the operation is fairly troublesome, andthe method can not carry out the differential display of the around tissues, that is the scope is too small etc.
Description
technical field [0001] The invention relates to a special colored perfusate for ophthalmic surgery. Background technique [0002] With the development of modern microsurgical instruments, microscopic instruments are widely used in ophthalmic surgery, and the intraocular surgery technology has become more and more perfect and mature. Cataract extraction has been widely carried out in hospitals at all levels, and vitreoretinal surgery has also begun to be gradually carried out in large and medium-sized hospitals, and the number has increased year by year, saving many blind or near-blind eyes. In ophthalmic surgery, the perfusate is in direct contact with the corneal endothelium, lens capsule, retina and other tissues in the eye, so there are strict requirements for the perfusate used in surgery, including the composition and pH of the perfusate, so as to minimize its impact on ocular tissues. injuries, especially those with long operating times. Ophthalmic balanced salt solu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K33/14A61P41/00
Inventor 宋宗明赵振全瞿佳王勤美
Owner SCHOOL OF OPHTHALMOLOGY & OPTOMETRY WENZHOU MEDICAL COLLEGE